PEGFILGRASTIM , Rinatabart Sesutecan
GCT1184-05
Phase 2 small_molecule active
Quick answer
PEGFILGRASTIM , Rinatabart Sesutecan for Locally advanced or metastatic Non-Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Genmab A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Genmab A/S
- Indication
- Locally advanced or metastatic Non-Small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active